학술논문
Remdesivir Alone or in Combination with Monoclonal Antibodies as an Early Treatment to Prevent Severe COVID-19 in Patients with Mild/Moderate Disease at High Risk of Progression: A Single Centre, Real-Life Study
Document Type
Article
Author
Source
In: Vaccines . (Vaccines, February 2023, 11(2))
Subject
Language
English
ISSN
2076393X